These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 34246314)

  • 1. Leukemia stem cell-bone marrow microenvironment interplay in acute myeloid leukemia development.
    Yao Y; Li F; Huang J; Jin J; Wang H
    Exp Hematol Oncol; 2021 Jul; 10(1):39. PubMed ID: 34246314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of the bone marrow niche in hematopoiesis, leukemogenesis, and chemotherapy resistance in acute myeloid leukemia.
    Wang A; Zhong H
    Hematology; 2018 Dec; 23(10):729-739. PubMed ID: 29902132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The genesis and evolution of acute myeloid leukemia stem cells in the microenvironment: From biology to therapeutic targeting.
    Chen Y; Li J; Xu L; Găman MA; Zou Z
    Cell Death Discov; 2022 Sep; 8(1):397. PubMed ID: 36163119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the bone marrow microenvironment in acute leukemia.
    Karantanou C; Godavarthy PS; Krause DS
    Leuk Lymphoma; 2018 Nov; 59(11):2535-2545. PubMed ID: 29431560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of Bone Marrow Microenvironment on Leukemic Stem Cells: Breaking Up an Intimate Relationship.
    Agarwal P; Bhatia R
    Adv Cancer Res; 2015; 127():227-52. PubMed ID: 26093902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Hypoxic Bone Marrow Microenvironment in Acute Myeloid Leukemia and Future Therapeutic Opportunities.
    Bruno S; Mancini M; De Santis S; Monaldi C; Cavo M; Soverini S
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34202238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug Resistance Mechanisms of Acute Myeloid Leukemia Stem Cells.
    Niu J; Peng D; Liu L
    Front Oncol; 2022; 12():896426. PubMed ID: 35865470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remodeling of the bone marrow microenvironment during acute myeloid leukemia progression.
    Urs AP; Goda C; Kulkarni R
    Ann Transl Med; 2024 Aug; 12(4):63. PubMed ID: 39118939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow microenvironment: The guardian of leukemia stem cells.
    Houshmand M; Blanco TM; Circosta P; Yazdi N; Kazemi A; Saglio G; Zarif MN
    World J Stem Cells; 2019 Aug; 11(8):476-490. PubMed ID: 31523368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recreating the Bone Marrow Microenvironment to Model Leukemic Stem Cell Quiescence.
    O'Reilly E; Zeinabad HA; Nolan C; Sefy J; Williams T; Tarunina M; Hernandez D; Choo Y; Szegezdi E
    Front Cell Dev Biol; 2021; 9():662868. PubMed ID: 34589478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of bone marrow microenvironment (BMM) cells in acute myeloid leukemia (AML) progression: immune checkpoints, metabolic checkpoints, and signaling pathways.
    Bakhtiyari M; Liaghat M; Aziziyan F; Shapourian H; Yahyazadeh S; Alipour M; Shahveh S; Maleki-Sheikhabadi F; Halimi H; Forghaniesfidvajani R; Zalpoor H; Nabi-Afjadi M; Pornour M
    Cell Commun Signal; 2023 Sep; 21(1):252. PubMed ID: 37735675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting BMP signaling in the bone marrow microenvironment of myeloid leukemia.
    Lefort S; Maguer-Satta V
    Biochem Soc Trans; 2020 Apr; 48(2):411-418. PubMed ID: 32167132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting acute myeloid leukemia stem cells: Current therapies in development and potential strategies with new dimensions.
    Tan Y; Wu Q; Zhou F
    Crit Rev Oncol Hematol; 2020 Aug; 152():102993. PubMed ID: 32502928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The non-cell-autonomous function of ID1 promotes AML progression via ANGPTL7 from the microenvironment.
    Fei MY; Wang Y; Chang BH; Xue K; Dong F; Huang D; Li XY; Li ZJ; Hu CL; Liu P; Wu JC; Yu PC; Hong MH; Chen SB; Xu CH; Chen BY; Jiang YL; Liu N; Zhao C; Jin JC; Hou D; Chen XC; Ren YY; Deng CH; Zhang JY; Zong LJ; Wang RJ; Gao FF; Liu H; Zhang QL; Wu LY; Yan J; Shen S; Chang CK; Sun XJ; Wang L
    Blood; 2023 Sep; 142(10):903-917. PubMed ID: 37319434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Far from Health: The Bone Marrow Microenvironment in AML, A Leukemia Supportive Shelter.
    Sendker S; Waack K; Reinhardt D
    Children (Basel); 2021 May; 8(5):. PubMed ID: 34066861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preservation of Quiescent Chronic Myelogenous Leukemia Stem Cells by the Bone Marrow Microenvironment.
    Shah M; Bhatia R
    Adv Exp Med Biol; 2018; 1100():97-110. PubMed ID: 30411262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A potential area of use for immune checkpoint inhibitors: Targeting bone marrow microenvironment in acute myeloid leukemia.
    Aru B; Pehlivanoğlu C; Dal Z; Dereli-Çalışkan NN; Gürlü E; Yanıkkaya-Demirel G
    Front Immunol; 2023; 14():1108200. PubMed ID: 36742324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic targeting of leukemia stem cells in acute myeloid leukemia.
    Barbosa K; Deshpande AJ
    Front Oncol; 2023; 13():1204895. PubMed ID: 37601659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of acute myeloid leukemia by directly targeting both leukemia stem cells and oncogenic molecule with specific scFv-immunolipoplexes as a deliverer.
    Wang GP; Qi ZH; Chen FP
    Med Hypotheses; 2008; 70(1):122-7. PubMed ID: 17566667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploiting epigenetically mediated changes: Acute myeloid leukemia, leukemia stem cells and the bone marrow microenvironment.
    Kogan AA; Lapidus RG; Baer MR; Rassool FV
    Adv Cancer Res; 2019; 141():213-253. PubMed ID: 30691684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.